Einstein develops blood test detecting 50+ cancer types in asymptomatic patients

Brazil's Hospital Israelita Albert Einstein has developed a blood-based test that detects over 50 cancer types in asymptomatic patients aged 50+, priced at R$ 6,990. The test's sensitivity and specificity are not detailed, and it is unclear if it is approved by regulators or available beyond private clinics. This could shift early cancer detection in Brazil, but validation and cost barriers remain.